Renal Research Lab, Centre for Bio-Medical Research, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
PLoS One. 2021 Nov 19;16(11):e0260116. doi: 10.1371/journal.pone.0260116. eCollection 2021.
Lactobacillus paragasseri was identified as a novel sister taxon of L. gasseri in 2018. Since the reclassification of L. paragasseri, there has been hardly any report describing the probiotic properties of this species. In this study, an L. paragasseri strain UBLG-36 was sequenced and analyzed to determine the molecular basis that may confer the bacteria with probiotic potential. UBLG-36 was previously documented as an L. gasseri strain. Average nucleotide identity and phylogenomic analysis allowed accurate taxonomic identification of UBLG-36 as an L. paragasseri strain. Analysis of the draft genome (~1.94 Mb) showed that UBLG-36 contains 5 contigs with an average G+C content of 34.85%. Genes essential for the biosynthesis of bacteriocins, adhesion to host epithelium, stress resistance, host immunomodulation, defense, and carbohydrate metabolism were identified in the genome. Interestingly, L. paragasseri UBLG-36 also harbored genes that code for enzymes involved in oxalate catabolism, such as formyl coenzyme A transferase (frc) and oxalyl coenzyme A decarboxylase (oxc). In vitro oxalate degradation assay showed that UBLG-36 is highly effective in degrading oxalate (averaging more than 45% degradation), a feature that has not been reported before. As a recently identified bacterium, there are limited genomic reports on L. paragasseri, and our draft genome sequence analysis is the first to describe and emphasize the probiotic potential and oxalate degrading ability of this species. With results supporting the probiotic functionalities and oxalate catabolism of UBLG-36, we propose that this strain is likely to have immense biotechnological applications upon appropriate characterization.
副干酪乳杆菌于 2018 年被鉴定为干酪乳杆菌的新型姊妹分类群。自副干酪乳杆菌重新分类以来,几乎没有任何报道描述该物种的益生菌特性。在这项研究中,对一株副干酪乳杆菌菌株 UBLG-36 进行了测序和分析,以确定可能赋予该细菌益生菌潜力的分子基础。UBLG-36 先前被记录为干酪乳杆菌菌株。平均核苷酸同一性和系统发育基因组分析允许对 UBLG-36 进行准确的分类鉴定,将其鉴定为副干酪乳杆菌菌株。对草图基因组(约 1.94 Mb)的分析表明,UBLG-36 包含 5 个平均 G+C 含量为 34.85%的 contigs。在基因组中鉴定了与细菌素生物合成、宿主上皮细胞黏附、应激抗性、宿主免疫调节、防御和碳水化合物代谢相关的必需基因。有趣的是,副干酪乳杆菌 UBLG-36 还含有编码参与草酸盐代谢的酶的基因,如甲酰辅酶 A 转移酶 (frc) 和草酰辅酶 A 脱羧酶 (oxc)。体外草酸盐降解试验表明,UBLG-36 具有高效降解草酸盐的能力(平均降解率超过 45%),这一特性以前尚未报道过。作为一种最近发现的细菌,关于副干酪乳杆菌的基因组报告有限,我们的草图基因组序列分析是首次描述和强调该物种的益生菌潜力和草酸盐降解能力。由于 UBLG-36 支持益生菌功能和草酸盐代谢,我们建议在适当表征后,该菌株很可能具有巨大的生物技术应用潜力。